YAYON; Avner

Patent Applications and Registrations

Patent applications and USPTO patent grants for YAYON; Avner.The latest application filed is for "methods and compositions for treating multiple sclerosis".

Company Profile

4.35.44

YAYON; Avner - Moshav Sitria IL
Yayon; Avner - Moshav IL
- Moshav Sitria IL
Yayon; Avner - Sitria IL
Yayon, Avner - US
Yayon, Avner - Siitria IL
Yayon; Avner - Rehovot IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Compositions For Treating Multiple Sclerosis App 20200223927 - YAYON; Avner ; et al.	2020-07-16
Fgf-2 Variants Having N-terminal Deletions And Increased Receptor Selectivity And Uses Thereof App 20180127475 - Yayon; Avner ; et al.	2018-05-10
FGF-2 variants having N-terminal deletions and increased receptor selectivity and methods of use thereof Grant 9,862,753 - Yayon , et al. January 9, 2	2018-01-09
Conjugates Of Carboxy Polysaccharides With Fibroblast Growth Factors And Variants Thereof App 20170196986 - YAYON; Avner ; et al.	2017-07-13
FGF-9 Variants and Methods of Use Thereof App 20170095533 - Bogin; Oren ; et al.	2017-04-06
Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof Grant 9,610,357 - Yayon , et al. April 4, 2	2017-04-04
FGF-2 variants and methods of use thereof Grant 9,487,568 - Bogin , et al. November 8, 2	2016-11-08
FGF-18 truncated variants having increased receptor specificity and uses thereof Grant 9,226,949 - Yayon , et al. January 5, 2	2016-01-05
Fgf-2 Variants Having N-terminal Deletions And Increased Receptor Selectivity And Uses Thereof App 20150322126 - Yayon; Avner ; et al.	2015-11-12
FGF-2 Variants and Methods of Use Thereof App 20150072426 - Bogin; Oren ; et al.	2015-03-12
FGF-2 variants having N-terminal deletions and increased receptor selectivity and uses thereof Grant 8,962,556 - Yayon , et al. February 24, 2	2015-02-24
Hydrazido derivatives of hyaluronic acid Grant 8,940,888 - Amit , et al. January 27, 2	2015-01-27
FGF-9 variants and methods of use thereof Grant 8,916,522 - Bogin , et al. December 23, 2	2014-12-23
Treatment Of Achondroplasia With Encapsulated Cnp-secreting Cells App 20140271868 - Golembo; Myriam ; et al.	2014-09-18
Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof Grant 8,828,385 - Yayon , et al. September 9, 2	2014-09-09
Conjugates Of Carboxy Polysaccharides With Fibroblast Growth Factors And Variants Thereof App 20140038892 - Yayon; Avner ; et al.	2014-02-06
Hydrazido Derivatives Of Hyaluronic Acid App 20140005141 - AMIT; Boaz ; et al.	2014-01-02
Freeze-dried fibrin matrices and methods for preparation thereof Grant 08618258 -	2013-12-31
Freeze-dried fibrin matrices and methods for preparation thereof Grant 8,618,258 - Yayon , et al. December 31, 2	2013-12-31
Fgf-9 Variants And Methods Of Use Thereof App 20130338070 - BOGIN; Oren ; et al.	2013-12-19
FGF-9 variants and methods for use thereof Grant 8,609,823 - Bogin , et al. December 17, 2	2013-12-17
Hydrazido derivatives of hyaluronic acid Grant 8,524,885 - Amit , et al. September 3, 2	2013-09-03
FGF-18 Truncated Variants Having Increased Receptor Specificity And Uses Thereof App 20130225493 - Yayon; Avner ; et al.	2013-08-29
Water Soluble Reactive Derivatives Of Carboxy Polysaccharides And Fibrinogen Conjugates Thereof App 20130084278 - Amit; Boaz ; et al.	2013-04-04
Method And Composition For Treatment Of Skeletal Dysplasias App 20120328699 - Golembo; Myriam ; et al.	2012-12-27
Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof Grant 8,329,870 - Amit , et al. December 11, 2	2012-12-11
Methods for bone regeneration using endothelial progenitor cell preparations Grant 8,298,528 - Yayon , et al. October 30, 2	2012-10-30
Freeze-dried Fibrin Matrices And Methods For Preparation Thereof App 20120219534 - Yayon; Avner ; et al.	2012-08-30
Fgf Variants And Methods For Use Thereof App 20120214739 - Bogin; Oren ; et al.	2012-08-23
Freeze-dried fibrin matrices and methods for preparation thereof Grant 8,193,317 - Yayon , et al. June 5, 2	2012-06-05
FGF variants and methods for use thereof Grant 8,119,783 - Bogin , et al. February 21, 2	2012-02-21
Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof Grant 8,101,721 - Yayon , et al. January 24, 2	2012-01-24
N-terminal Fgf Variants Having Increased Receptor Selectivity And Uses Thereof App 20110053841 - Yayon; Avner ; et al.	2011-03-03
Bone enhancing composite Grant 7,887,831 - Yayon February 15, 2	2011-02-15
Cartilage particle tissue mixtures optionally combined with a cancellous construct App 20100274362 - Yayon; Avner ; et al.	2010-10-28
Freeze-dried Fibrin Matrices And Methods For Preparation Thereof App 20100178314 - Yayon; Avner ; et al.	2010-07-15
Freeze-dried fibrin matrices and methods for preparation thereof Grant 7,714,107 - Yayon , et al. May 11, 2	2010-05-11
Water Soluble Reactive Derivatives Of Carboxy Polysaccharides And Fibrinogen Conjugates Thereof App 20100086594 - Amit; Boaz ; et al.	2010-04-08
Antibodies Blocking Fibroblast Growth Factor Receptor Activation And Methods Of Use Thereof App 20100047251 - Yayon; Avner ; et al.	2010-02-25
Methods For Bone Regeneration Using Endothelial Progenitor Cell Preparations App 20100003222 - Yayon; Avner ; et al.	2010-01-07
Fgf Variants And Methods For Use Thereof App 20090247462 - Bogin; Oren ; et al.	2009-10-01
Antibodies That Block Receptor Protein Tyrosine Kinase Activation, Methods Of Screening For And Uses Thereof App 20090202547 - Yayon; Avner ; et al.	2009-08-13
FGF variants and methods for use thereof Grant 7,563,769 - Bogin , et al. July 21, 2	2009-07-21
Treatment Of B-cell Malignancies App 20090175866 - Yayon; Avner ; et al.	2009-07-09
Chondrocyte-based Implant For The Delivery Of Therapeutic Agents App 20090155229 - Yayon; Avner	2009-06-18
Hydrazido Derivatives Of Hyaluronic Acid App 20090149419 - Amit; Boaz ; et al.	2009-06-11
Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof Grant 7,498,416 - Yayon , et al. March 3, 2	2009-03-03
Method And Composition For Treatment Of Skeletal Dysplasias App 20080194682 - Golembo; Myriam ; et al.	2008-08-14
Porous plasma protein matrices and methods for preparation thereof Grant 7,335,508 - Yayon , et al. February 26, 2	2008-02-26
Treatment of T Cell Mediated Diseases by Inhibition of Fgfr3 App 20080044419 - Yayon; Avner	2008-02-21
Active variants of FGF with improved specificity Grant 7,288,406 - Bogin , et al. October 30, 2	2007-10-30
Method and composition for treatment of skeletal dysplasias Grant 7,276,481 - Golembo , et al. October 2, 2	2007-10-02
Thermoanaerobacter brockii alcohol dehydrogenase promoter for expression of heterologous proteins Grant 7,264,946 - Bogin , et al. September 4, 2	2007-09-04
Freeze-dried fibrin matrices and methods for preparation thereof App 20060172008 - Yayon; Avner ; et al.	2006-08-03
Bone enhancing composite App 20060147547 - Yayon; Avner	2006-07-06
Plasma protein matrices and methods for their preparation Grant 7,009,039 - Yayon , et al. March 7, 2	2006-03-07
Porous plasma protein matrices and methods for preparation thereof App 20060019389 - Yayon; Avner ; et al.	2006-01-26
FGF variants and methods for use thereof App 20050148511 - Bogin, Oren ; et al.	2005-07-07
Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof App 20050147612 - Yayon, Avner ; et al.	2005-07-07
Cd44 variants carrying heparan sulfate chains and uses thereof App 20050054560 - Yayon, Avner ; et al.	2005-03-10
Plasma protein matrices and methods for their preparation App 20040209359 - Yayon, Avner ; et al.	2004-10-21
Method and composition for treatment of skeletal dysplasias App 20040138134 - Golembo, Myriam ; et al.	2004-07-15
Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives Grant 6,730,666 - Yayon , et al. May 4, 2	2004-05-04
High level expression of heterologous proteins App 20040058348 - Bogin, Oren ; et al.	2004-03-25
Active variants of FGF with improved specificity App 20040014658 - Bogin, Oren ; et al.	2004-01-22
Screening assay for antagonists of FGFR-mediated malignant cell transformation and tumor formation App 20040014024 - Yayon, Avner ; et al.	2004-01-22
FGFR3 as a marker for mesenchymal skeletal progenitor cells App 20030206912 - Yayon, Avner ; et al.	2003-11-06
Proteoglycans and pharmaceutical compositions comprising them App 20030100492 - Yayon, Avner	2003-05-29
FGFR3 as a marker for mesenchymal skeletal progenitor cells Grant 6,517,872 - Yayon , et al. February 11, 2	2003-02-11
FGF9 as a specific ligand for FGFR3 App 20020193309 - Yayon, Avner	2002-12-19
Animal model for fibroblast growth factor receptor associated chondrodysplasia Grant 6,265,632 - Yayon , et al. July 24, 2	2001-07-24
System for assaying binding to a heparin-binding growth factor receptor Grant 5,789,182 - Yayon , et al. August 4, 1	1998-08-04
Cells expressing a substantial number of surface high affinity HBGF receptors but relatively few low affinity HBGF binding sites and system for assaying binding to HBGF receptor Grant 5,270,197 - Yayon , et al. December 14, 1	1993-12-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.